(Q46431176)

22 December 2017

title

CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat. (English)

1 reference

22 December 2017

0 references

0 references

0 references

Styliani Vlachou

1

1 reference

22 December 2017

George G Nomikos

series ordinal

2

1 reference

22 December 2017

George Panagis

series ordinal

3

1 reference

22 December 2017

publication date

18 November 2004

1 reference

22 December 2017

number of pages

11

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

22 December 2017

volume

179

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

498-508

1 reference

22 December 2017

Blockade of the reward-potentiating effects of nicotine on lateral hypothalamic brain stimulation by chlorisondamine

cites work

1 reference

12 December 2020

A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

1 reference

12 December 2020

Effects of concomitant motor reactions on the measurement of rewarding efficacy of brain stimulation

1 reference

12 December 2020

Brain dopamine and reward

1 reference

12 December 2020

Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm

1 reference

12 December 2020

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

1 reference

12 December 2020

Fitting intracranial self-stimulation data with growth models

1 reference

12 December 2020

Pimozide blocks reinforcement but not priming from MFB stimulation in the rat.

1 reference

12 December 2020

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

1 reference

12 December 2020

Pimozide and amphetamine have opposing effects on the reward summation function

1 reference

12 December 2020

Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.

1 reference

12 December 2020

Cannabinoid receptors and reward in the rat: a conditioned place preference study.

1 reference

12 December 2020

Cannabis and the brain

1 reference

12 December 2020

Cannabis: pharmacology and toxicology in animals and humans

1 reference

12 December 2020

Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains.

1 reference

12 December 2020

Delta 9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism.

1 reference

12 December 2020

Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation

1 reference

12 December 2020

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

1 reference

12 December 2020

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

1 reference

12 December 2020

Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system

1 reference

12 December 2020

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

12 December 2020

The curve-shift paradigm in self-stimulation

1 reference

12 December 2020

Intravenous self-administration of drugs in rats

1 reference

12 December 2020

Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts

1 reference

12 December 2020

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

12 December 2020

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys

1 reference

12 December 2020

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9-Tetrahydrocannabinol-Tolerant Rats

1 reference

12 December 2020

Effects of delta9-THC and WIN-55,212-2 on place preference in the water maze in rats

1 reference

12 December 2020

Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits

1 reference

12 December 2020

THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.

1 reference

12 December 2020

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

1 reference

12 December 2020

Pharmacology of cannabinoid receptor ligands.

1 reference

12 December 2020

Cannabinoid transmission and reward-related events

1 reference

12 December 2020

Conditioned taste aversion induced by self-administered drugs: paradox revisited

1 reference

12 December 2020

Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol

1 reference

12 December 2020

Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm

1 reference

12 December 2020

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

1 reference

12 December 2020

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors

1 reference

12 December 2020

Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation.

1 reference

12 December 2020

Drugs of abuse: biochemical surrogates of specific aspects of natural reward?

1 reference

12 December 2020

(R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.

1 reference

12 December 2020

The endocannabinoid nervous system: unique opportunities for therapeutic intervention

1 reference

12 December 2020

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

12 December 2020

WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation

1 reference

12 December 2020

Opioid-neuroleptic interaction in brainstem self-stimulation

1 reference

12 December 2020

Self-administration of Δ9-tetrahydrocannabinol by rats

1 reference

12 December 2020

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

1 reference

12 December 2020

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

12 December 2020

SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats

1 reference

12 December 2020

Catecholamines and self-stimulation: reward and performances effects dissociated

1 reference

12 December 2020

Action of drugs of abuse on brain reward systems

1 reference

12 December 2020

Pharmacology of cannabinoids

1 reference

12 December 2020

Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys.

1 reference

12 December 2020

The effects of systemic and intracerebral injections of D1 and D2 agonists on brain stimulation reward

1 reference

12 December 2020

Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.

1 reference

12 December 2020

Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol

1 reference

12 December 2020

Drug-activation of brain reward pathways

1 reference

12 December 2020

Cannabinoid receptors and their endogenous agonists

1 reference

12 December 2020

Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice

1 reference

12 December 2020

Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats

1 reference

12 December 2020

Behavioral effects of cannabinoid agents in animals

1 reference

12 December 2020

Cannabinoids. I. Behavioral effects.

1 reference

12 December 2020

The effects of cannabinoids on the brain

1 reference

12 December 2020

Effects of cocaine and GBR-12909 on brain stimulation reward

1 reference

12 December 2020

Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance

1 reference

12 December 2020

The effects of levonantradol on rewarding brain stimulation thresholds in the rat.

1 reference

12 December 2020

Neuroleptic-induced attenuation of brain stimulation reward in rats

1 reference

12 December 2020

The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive

1 reference

12 December 2020

Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats

1 reference

12 December 2020

Cannabis is more than simply delta(9)-tetrahydrocannabinol

1 reference

12 December 2020

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

1 reference

12 December 2020

Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward.

1 reference

12 December 2020

Quantitative determination of the effects of catecholaminergic agonists and antagonists on the rewarding efficacy of brain stimulation.

1 reference

12 December 2020

Discriminating between reward and performance: A critical review of intracranial self-stimulation methodology

1 reference

12 December 2020

Cannabinergic ligands

1 reference

12 December 2020

Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward.

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

12 December 2020

Delta 9-tetrahydrocannabinol: aversive effects in rat at high doses.

1 reference

12 December 2020

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

1 reference

12 December 2020

The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats

1 reference

12 December 2020

Failure of Delta(9)-tetrahydrocannabinol and CP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys

1 reference

12 December 2020

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

12 December 2020

Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

1 reference

12 December 2020

Addictive Drugs and Brain Stimulation Reward

1 reference

12 December 2020

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

1 reference

12 December 2020

Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations

1 reference

12 December 2020

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.

1 reference

12 December 2020

Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data

1 reference

12 December 2020

Aversive effects of the synthetic cannabinoid CP 55,940 in rats.

1 reference

12 December 2020

10.1007/S00213-004-2050-0

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017